| Shannon Brooke Leffler, | |
|
13900 Hull Street Rd, Midlothian, VA 23112-2004 | |
| (804) 639-8900 | |
| Not Available |
| Full Name | Shannon Brooke Leffler |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 13900 Hull Street Rd, Midlothian, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235880469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119004898 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Brooke Leffler, 13900 Hull Street Rd, Midlothian, VA 23112-2004 Ph: () - | Shannon Brooke Leffler, 13900 Hull Street Rd, Midlothian, VA 23112-2004 Ph: (804) 639-8900 |
News Archive
An anti-inflammatory treatment, studied in the labs of regenerative medicine specialists and trauma surgeons, may prevent what's become one of the war-defining injuries for today's troops.
A new study published in the journal Pediatrics on Monday examined the risks of consumption of high-caffeine energy drinks on children and young adults. The study notes that these drinks are linked to an array of serious events like heart palpitations, high blood pressure and even cardiac arrest and death. The risk rises if young adults consuming the drink suffer from chronic diseases or take other medications.
Boston College biologist Ken Williams, whose research focuses on the role of immunological cells in a range of illnesses that strike people living with HIV and AIDS, has been awarded a five-year, $2.7 million grant from the NIH's National Institute of Neurological Disorders and Stroke.
Rahm Gummuluru, PhD, associate professor of microbiology at Boston University School of Medicine, and Bjoern Reinhard, PhD, professor of chemistry at Boston University, have been awarded a Research Project Grant from the National Institutes of Allergy and Infectious Diseases/National Institute of Health.
The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.
› Verified 8 days ago
Lanetta Pressley, M.S.,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15008 Rosebay Forest Dr, Midlothian, VA 23112 Phone: 804-363-9756 | |
Independence By Design Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14318 Denby Ter, Midlothian, VA 23114 Phone: 804-794-1333 Fax: 804-379-8664 | |
Leah Reed, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13800 Bon Secours Dr, Midlothian, VA 23114 Phone: 804-712-1227 | |
Julie Diana Gronboldt, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14201 Broad Oaks Ct, Midlothian, VA 23112 Phone: 804-312-6154 | |
Michelle Wallace Allen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13424 Welby Ct, Midlothian, VA 23113 Phone: 804-986-7224 | |
Mrs. Claire Emory Rose, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Coalfield Rd, Midlothian, VA 23114 Phone: 804-897-7440 | |
Dustin Ryan Mays, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2100 Brandermill Pkwy, Midlothian, VA 23112 Phone: 804-379-7100 |